CLINICAL_TRIALS
other
· 2024-12-16
Clinical Trial Update: Zr-89 Cimzia PET Imaging Rheumatoid Arthritis [Phase 1]
Summary
The phase 1 trial of zirconium-89 labeled Cimzia for PET imaging in rheumatoid arthritis is currently suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Robert Flavell, MD, PhD | Conditions: Rheumatoid Arthritis | Phase 1 | Status: SUSPENDED